1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South America Injection Pen Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South America Injection Pen Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South America Injection Pen Market Regional Analysis
6.2 South America Injection Pen Market Revenue 2020-2028 (US$ Million)
6.3 South America Injection Pen Market Forecast Analysis
7. South America Injection Pen Market Analysis – by Type
7.1 Disposable Injection Pens
- 7.1.1 Overview
- 7.1.2 Disposable Injection Pens: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Reusable Injection Pens
- 7.2.1 Overview
- 7.2.2 Reusable Injection Pens: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. South America Injection Pen Market Analysis – by Therapy
8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Growth Hormone Therapy
- 8.2.1 Overview
- 8.2.2 Growth Hormone Therapy: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Autoimmune Diseases
- 8.3.1 Overview
- 8.3.2 Autoimmune Diseases: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Fertility
- 8.4.1 Overview
- 8.4.2 Fertility: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Cancer
- 8.5.1 Overview
- 8.5.2 Cancer: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Others Therapy
- 8.6.1 Overview
- 8.6.2 Others Therapy: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. South America Injection Pen Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Home Care
- 9.2.1 Overview
- 9.2.2 Home Care: South America Injection Pen Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. South America Injection Pen Market – South and Central America Analysis
10.1 Overview
10.2 South and Central America
- 10.2.1 South America Injection Pen Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 South America Injection Pen Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 Brazil: South America Injection Pen Market Breakdown, by Type
- 10.2.1.1.2 Brazil: South America Injection Pen Market Breakdown, by Therapy
- 10.2.1.1.3 Brazil: South America Injection Pen Market Breakdown, by End User
- 10.2.1.2 Argentina:
South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Argentina: South America Injection Pen Market Breakdown, by Type
- 10.2.1.2.2 Argentina: South America Injection Pen Market Breakdown, by Therapy
- 10.2.1.2.3 Argentina: South America Injection Pen Market Breakdown, by End User
- 10.2.1.3 Rest of South and Central America :
South America Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America : South America Injection Pen Market Breakdown, by Type
- 10.2.1.3.2 Rest of South and Central America : South America Injection Pen Market Breakdown, by Therapy
- 10.2.1.3.3 Rest of South and Central America : South America Injection Pen Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 AstraZeneca Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Becton Dickinson and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Eli Lilly and Co
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Gerresheimer AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Haselmeier GmbH
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Novo Nordisk AS
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Owen Mumford Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sanofi SA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations